SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-092905
Filing Date
2020-08-11
Accepted
2020-08-10 20:23:22
Documents
15
Period of Report
2020-08-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2027106-1_8k.htm   iXBRL 8-K 33223
2 EXHIBIT 5.1 tm2027106d1_ex5-1.htm EX-5.1 12459
3 GRAPHIC tm2027106d1_ex5-1img001.jpg GRAPHIC 1803
4 GRAPHIC tm2027106d1_ex5-1img002.jpg GRAPHIC 34105
  Complete submission text file 0001104659-20-092905.txt   271993

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ptct-20200810.xsd EX-101.SCH 3180
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptct-20200810_lab.xml EX-101.LAB 34591
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptct-20200810_pre.xml EX-101.PRE 22706
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2027106-1_8k_htm.xml XML 3500
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 201090828
SIC: 2834 Pharmaceutical Preparations